New drug candidates for treating radiation poisoning
Nature Medicine
June 25, 2012
Two new drug candidates for treating radiation poisoning are uncovered in a study published online this week in Nature Medicine.
Hartmut Geiger and colleagues use a genetic screen to identify new regulators of radiation sensitivity in mice and discover that a pathway that controls blood clotting and inflammation unexpectedly provides protection against radiation damage. In this pathway, the protein thrombomodulin helps generate activated protein C, which has both anticoagulant and anti-inflammatory activities. The team found that intravenous infusion of recombinant forms of either thrombomodulin or activated protein C protected mice from death after total body radiation.
Both thrombomodulin and activated protein C have previously been used in humans for other conditions, suggesting they might be repurposed for treating radiation poisoning.
doi: 10.1038/nm.2813
Research highlights
-
May 12
Geoscience: Monitoring earthquakes at the speed of lightNature
-
May 4
Microbiology: Bacteriophage therapy helps treat multi-drug resistant infection in an immunocompromised patientNature Communications
-
Apr 27
Planetary science: Building blocks of DNA detected in meteoritesNature Communications
-
Apr 8
Health: Psilocybin use associated with lower risk of opioid addictionScientific Reports
-
Apr 5
Energy: Winterizing the Texan energy infrastructure pays off in the long termNature Energy
-
Mar 17
Neuroscience: Sample size matters in studies linking brain scans to behaviourNature
